12 June 2026 · 6 min read
Companies introducing a regulated product into the United Arab Emirates often treat registration as a late-stage administrative task. In practice, classification, claims and labelling decisions made months earlier determine how difficult the filing will be.
Regulatory planning is most useful while the product is still being specified: when the formula can change, when claims can be moderated, and when artwork has not been printed.
Start with intended use, not the brand calendar
The first questions are simple. What is the product? Who is it for? What does the pack say it does? Those answers affect category treatment in the UAE more than the commercial name or the fact that the product is already sold elsewhere.
A supplement-style presentation, a cosmetic claim or a therapeutic statement can move the same composition onto a different pathway. That discussion belongs at the beginning of a UAE launch, not after a distributor has booked a listing.
Build a document list before requesting everything
Manufacturers are frequently asked for a long, unfocused list of certificates. A more reliable method is to map the likely UAE process for the category, then request the documents that process actually uses.
Gap analysis at this stage also shows whether testing, artwork or company papers will take longer than the intended ship date.
Treat Arabic labelling as a regulatory document
Bilingual artwork is not only a design task. Mandatory particulars, warnings and ingredient lists have to remain consistent with the technical file. Once plates are made, corrections become expensive and can delay submission.
MEPA’s view is that label review should sit alongside classification and documentation planning, not after the file is otherwise complete.
This article is general information only. See the regulatory disclaimer.